enkephalin, leucine has been researched along with Bodily Distress Disorder in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andriushenko, AV; Gabaeva, MV; Kost, NV; Miasoedov, NF; Neznamov, GG; Serebriakova, EV; Seredenin, SB; Siranchieva, OA; Siuniakov, SA; Siuniakov, TS; Smulevich, AB; Sokolov, OIu; Telesheva, ES; Zozulia, AA | 1 |
1 trial(s) available for enkephalin, leucine and Bodily Distress Disorder
Article | Year |
---|---|
[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Dose-Response Relationship, Drug; Enkephalins; Female; Follow-Up Studies; Humans; Male; Medazepam; Middle Aged; Neurasthenia; Oligopeptides; Psychometrics; Severity of Illness Index; Treatment Outcome | 2008 |